what is the main difference between semaglutide and tirzepatide vs πβοΈ Both are powerful medications for diabetes weight loss, but tirzepatide's dual GIP + GLP-1 action may lead to even greater weight loss and glucose control. Semaglutide offers π Semaglutide vs. Tirzepatide β
Description
Research news Mouse experiments have suggested that glucagon-like peptide-1 receptor agonists may reduce pulmonary fibrosis following a COVID-19 infection in people with type 2 diabetes, although researchers cautioned that the findings remain preliminary Glucagon-like peptide-1 (GLP-1) receptor agonists, already used to treat type 2 diabetes (T2DM) and obesity, may also help to reduce the risk of COVID-19-related lung scarring in people with T2DM, according to research in mouse models
Both tirzepatide and semaglutide are well-characterised in type 2 diabetes research models, with extensive phase 3 trial data supporting their use in glycaemic endpoint studies

2013;28(Suppl 4):iV8298

Am J Cardiol 102: 19L27L

0.4% for semaglutide) with discontinuation rates of 6-8.5% vs

That is why the weight loss curves are genuinely different, not just incrementally better